alpha-En (ALPE) 10-K 20 Oct 16 2015 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Oct. 11, 2016	Jun. 30, 2015
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY
Entity Registrant Name	alpha-En Corp
Entity Central Index Key	1,023,298
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	No
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 25.3
Trading Symbol	ALPE
Entity Common Stock, Shares Outstanding		30,094,186

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Current assets
Cash	$ 730	$ 103
Prepaid expenses	301	5
Due from related party	61	0
Total current assets	1,092	108
Property and equipment, net	2	0
Total assets	1,094	108
Current liabilities
Accounts payable and accrued expenses	341	19
Advances from related parties	62	138
Total current liabilities	403	157
Total liabilities	403	157
COMMITMENTS AND CONTINGENCIES
Shareholders' equity (deficit):
Preferred stock par value $0.01: 2,000,000 shares authorized; none issued or outstanding	0	0
Common stock	286	267
Additional paid-In capital	10,741	8,130
Treasury stock at cost: 714,750 shares	(69)	(69)
Accumulated deficit	(10,169)	(8,377)
Shareholders' equity (deficit) attributed to alpha-En Corp.	789	(49)
Non-controlling interest	(98)
Total shareholders' equity (deficit)	691	(49)
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)	1,094	108
Common Class B [Member]
Shareholders' equity (deficit):
Common stock	$ 0	$ 0

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2015	Dec. 31, 2014
Preferred Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Preferred Stock, Shares Authorized	2,000,000	2,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares Authorized	35,000,000	35,000,000
Common Stock, Shares, Issued	28,649,497	26,699,497
Common Stock, Shares, Outstanding	28,649,497	26,699,497
Treasury Stock, Shares	714,750	714,750
Common Class B [Member]
Common Stock, No Par Value	$ 0	$ 0
Common Stock, Shares Authorized	1,000,000	1,000,000
Common Stock, Shares, Issued	0	0
Common Stock, Shares, Outstanding	0	0

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Operating expenses
General and administrative	$ 1,197	$ 103
Legal and professional fees	150	8
Research and development	494	16
Total operating expenses	1,841	127
Loss from operations	(1,841)	(127)
Other income
Gain on extinguishment of debt	0	80
Total other income	0	80
Net loss	(1,841)	(47)
Less: net loss attributable to non-controlling interest	(49)	0
Net loss attributable to alpha-En Corp.	$ (1,792)	$ (47)
Net loss per share attributable to alpha common shareholders
Basic and diluted	$ (0.07)	$ 0
Weighted average shares outstanding:
Basic and diluted	27,263,059	26,394,554

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Deficit [Member]	Noncontrolling Interest [Member]
Balance at Dec. 31, 2013	$ (252)	$ 258	$ 7,889	$ (69)	$ (8,330)	$ 0
Balance (In Shares) at Dec. 31, 2013		25,829,932		714,750
Shares issued for debt settlement - related party	50	$ 9	41	$ 0	0	0
Shares issued for debt settlement - related party (In Shares)		869,565		0
Sale of subsidiary common stock and warrants for cash	150	$ 0	150	$ 0	0	0
Stock based compensation	50	0	50	0	0	0
Net loss	(47)	0	0	0	(47)	0
Balance at Dec. 31, 2014	(49)	$ 267	8,130	$ (69)	(8,377)	0
Balance (In Shares) at Dec. 31, 2014		26,699,497		714,750
Sale of subsidiary common stock and warrants for cash	765	$ 0	814	$ 0	0	(49)
Stock based compensation	981	0	981	0	0	0
Issuance of restricted stock to employee	0	$ 3	(3)	$ 0	0	0
Issuance of restricted stock to employee (In Shares)		350,000		0
Issuance of common stock and warrants in a private placement	835	$ 16	819	$ 0	0	0
Issuance of common stock and warrants in a private placement (In Shares)		1,600,000		0
Net loss	(1,792)	$ 0	0	$ 0	(1,792)	(49)
Balance at Dec. 31, 2015	$ 691	$ 286	$ 10,741	$ (69)	$ (10,169)	$ (98)
Balance (In Shares) at Dec. 31, 2015		28,649,497		714,750

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities
Net loss	$ (1,841)	$ (47)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	981	50
Gain on extinguishment of accounts payable	0	(80)
Changes in operating assets and liabilities of business
Prepaid expenses and due from related parties	(357)	(5)
Accounts payable and accrued expenses	322	(13)
Net cash used in operating activities	(895)	(95)
Cash flows from investing activities
Purchase of fixed assets	(2)	0
Net cash used in investing activities	(2)	0
Cash flows from financing activities
Issuance of subsidiary common stock and warrants for cash	765	150
Proceeds from issuance of common stock and warrants in a private placement	835	0
Advances from related parties	11	60
Repayments of advances from related parties	(87)	(13)
Net cash provided by financing activities	1,524	197
Net increase in cash	627	102
Cash at beginning of period	103	1
Cash at end of period	730	103
Non cash financing and investing activities:
Shares issued for debt settlement - related party	0	50
Issuance of restricted stock to employee	$ 3	$ 0

Organization and Operations

Organization and Operations	12 Months Ended
	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations [Text Block]	Note 1 - Organization and Operations alpha-En Corporation (together with its subsidiaries, the “Company”) was incorporated in Delaware on March 7, 1997 and had operated through its wholly-owned subsidiaries, Avenue Pictures, Inc. and its subsidiaries and Wombat Productions, Inc. through May 2, 2006. On June 9, 2008, the Company name changed to alpha-En Corporation. Since 2008, the focus of alpha-En Corporation’s business has been developing new technologies for manufacturing highly pure lithium metal, a raw material for use in lightweight, high energy density batteries, in an environmentally friendly manner for commercial purposes. On February 25, 2009, alpha-En Corporation was granted a license for an exclusive worldwide, transferable, perpetual license to use certain proprietary technology for the production of lithium for use in batteries. After much effort, it was determined the process was not commercially feasible and efforts surrounding this technology were abandoned in 2011. We are currently negotiating an amendment and release related to this license. In 2011-2012 alpha-En Corporation devoted its resources to developing proprietary technology to produce highly pure lithium metal. In 2013, alpha-En Corporation invented a new process for the production of highly pure lithium metal and associated products at room temperature and subsequently broadened its focus to develop products and processes derived from its new core proprietary technology, including battery components and compounds of lithium. During the years 2013- the present, alpha-En Corporation has been exclusively focused on developing its own technology, from the bench scale through multiple validations, with the end goal of commercialization. During this time, alpha-En Corporation has also been pursuing strategic partnerships both commercially and with research institutions. Formation of Majority-Owned Subsidiary In September 2014, alpha-En Corporation formed Clean Lithium Corporation (“CLC”) under the laws of New York State as a wholly owned subsidiary with a nominal share capital of $ 100,000 Shares Warrant Value Common Stock Warrants Strike Price Common Stock Warrants Total 2014 October 13, 2014 Clean Lithium Corporation 150,000 - $ 123,000 $ - $ 123,000 alpha-En Corporation - 150,000 $ 0.20 - 27,000 27,000 150,000 150,000 $ 123,000 $ 27,000 $ 150,000 2015 April 28, 2015 Clean Lithium Corporation 100,000 - $ 61,000 $ - $ 61,000 alpha-En Corporation - 350,000 $ 0.40 - 39,000 39,000 July 30, 2015 Clean Lithium Corporation 300,000 - 300,000 - 300,000 alpha-En Corporation - 1,000,000 $ 0.20 - 50,000 50,000 August 28, 2015 Clean Lithium Corporation 180,000 - 180,000 - 180,000 alpha-En Corporation - 100,000 $ 0.20 - 5,000 5,000 December 3, 2015 Clean Lithium Corporation 100,000 - 100,000 - 100,000 alpha-En Corporation - 250,000 $ 0.77 - 30,000 30,000 680,000 1,700,000 $ 641,000 $ 124,000 $ 765,000 Shareholder Shares Percentage alpha-En Corporation 9,170,000 91.70 % Non-controlling interests 830,000 8.30 % Total: 10,000,000 100.00 %

Significant and Critical Accoun

Significant and Critical Accounting Policies and Practices	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 2 - Significant and Critical Accounting Policies and Practices The accompanying consolidated financial statements include the accounts of the Company’s subsidiaries. For consolidated entities where the Company owns less than 100% of the subsidiary, the Company records net income (loss) attributable to non-controlling interests in its consolidated statements of operations equal to the percentage of the economic or ownership interest retained in such entities by the respective non-controlling parties. The Company may consolidate subsidiaries in which it owns less than 50% of the subsidiary but maintains voting control. The Company’s consolidated financial statements include the accounts of the Company and its subsidiaries: Avenue Pictures, Inc., Wombat Productions, Inc. and Clean Lithium Corporation. All intercompany balances and transactions have been eliminated. The Company’s consolidated financial statements include certain amounts that are based on management’s best estimates and judgments. The Company’s significant estimates include, but are not limited to, useful lives assigned to long-lived assets, fair value measurements, stock-based compensation, accrued expenses, provisions for income taxes and contingencies. Due to the uncertainty inherent in such estimates, actual results may differ from these estimates. Fair Value Measurement The Company follows accounting guidance on fair value measurements for financial assets and liabilities measured at fair value on a recurring basis. Under the accounting guidance, fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. The accounting guidance requires fair value measurements be classified and disclosed in one of the following three categories: Level 1 Level 2: Level 3: The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability. Accounts Payable and Accrued Expenses. As of December 31, 2015 and 2014, substantially all of the Company’s cash was held by major financial institutions and the balance at certain times may exceed the maximum amount insured by the Federal Deposits Insurance Corporation (“FDIC”). However, the Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts. Office equipment is recorded at cost and depreciated using the straight-line method over the estimated useful life of each asset, generally five years. The Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value. The Company accounts for the issuance of common stock purchase warrants issued in connection with the equity offerings in accordance with the provisions of ASC 815, Derivatives and Hedging (“ASC 815”). The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net-cash settle the contract if an event occurs and if that event is outside the control of the Company) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses the classification of its common stock purchase warrants as of the date of each offering and reassesses such classification at each financial reporting date. The Company determined that such instruments did not meet the criteria for liability classification. Research and development costs are expensed as incurred. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. Upfront and milestone payments due to third parties that perform research and development services on the Company’s behalf will be expensed as services are rendered or when the milestone is achieved. Research and development costs primarily consist of personnel related expenses, including salaries, benefits, travel, and other related expenses, stock-based compensation, payments made to third parties for license and milestone costs related to in-licensed products and technology, payments made to third party contract research organizations, consultants, the cost of acquiring and manufacturing research trial materials, and costs associated with regulatory filings, laboratory costs and other supplies. In accordance with ASC 730-10-25-1, Research and Development The Company records accruals for contingencies and legal proceedings expected to be incurred in connection with a loss contingency when it is probable that a liability has been incurred and the amount can be reasonably estimated. If a loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed. The Company expenses stock-based compensation to employees over the requisite service period based on the estimated grant-date fair value of the awards and forfeiture rates. For stock-based compensation awards to non-employees, the Company remeasures the fair value of the non-employee awards at each reporting period prior to vesting and finally at the vesting date of the award. Changes in the estimated fair value of these non-employee awards are recognized as compensation expense in the period of change. The Company estimates the fair value of stock options grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is greater than 50% likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit. During the year ended December 31, 2014, the Company settled outstanding debt of $90,000 with its predecessor auditor, Schulman Wolfson & Abruzzo, LLP for $ 10,000 80,000 Basic loss per share of common stock is computed by dividing net loss applicable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted loss per share excludes the potential impact of common stock options, unvested shares of restricted stock and outstanding common stock purchase warrants because their effect would be anti-dilutive. As of December 31, 2015 2014 Warrants to purchase common stock 1,850,000 - Options to purchase common stock 3,720,000 2,520,000 Unvested restricted stock 650,000 - Total 6,220,000 2,520,000 Non-controlling interests in consolidated entities represent the component of equity in consolidated entities held by third parties. Any change in ownership of a subsidiary while the controlling financial interest is retained is accounted for as an equity transaction between the controlling and non-controlling interests. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) In March 2016, the FASB issued ASU No. 2016-09, Compensation-Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”)

Going Concern and Liquidity

Going Concern and Liquidity	12 Months Ended
	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Substantial Doubt about Going Concern [Text Block]	Note 3 – Going Concern and Liquidity The Company has elected to adopt early application of Accounting Standards Update No. 2014-15, “Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”) The Company’s consolidated financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As reflected in the consolidated financial statements, the Company had an accumulated deficit of approximately $ 10.2 8.4 1.8 47,000 895,000 95,000 The Company is attempting to further develop the intellectual property associated with its technology; broaden its patent portfolio; scale up our production of various products; and begin generating revenue; however, the Company’s cash position may not be sufficient to support its daily operations. While the Company believes in the viability of its technology and in its ability to raise additional funds by way of a public or private offering, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon its ability to raise additional funds by way of a public or private offering and its ability to further develop its technology and generate sufficient revenue. The consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 4 – Property and Equipment As of December 31, ($ in thousands) Useful Life (Years) 2015 2014 Lab equipment 5 $ 2 $ - Total property and equipment 2 - Less: Accumulated depreciation - - Property and equipment, net $ 2 $ - The Company’s depreciation expense for the years ended December 31, 2015 and 2014 was $ 0

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2015
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 5 – Related Party Transactions Advances from Related Parties From time to time, stockholders of the Company advance funds to the Company for working capital purpose. Those advances are unsecured, non-interest bearing and due on demand. During the year ended December 31, 2015, the Company borrowed approximately $ 11,000 87,000 60,000 13,000 869,565 50,000 62,000 138,000 Free Office Space The Company has been provided office space by its Chairman of the Board at no cost. The management determined that such cost is nominal and did not recognize the rent expense in its financial statements. Restricted Stock Grant to Chief Executive Officer and Associated Withholding Payments As of December 31, 2015, due to the timing of a December grant of restricted stock, Steven M. Fludder, Chief Executive Officer, incurred a withholding tax obligation of $ 60,826 60,826 Other The Chairman of the Board's son is an employee of the Company. His primary role is marketing and business development. The son of a member of the Board of Directors was hired to provide web site development and in 2014 received an option for 420,000 0.20 55,000

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	12 Months Ended
	Dec. 31, 2015
Equity [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Note 6 – Stockholders’ Equity (Deficit) Shares Authorized The total number of shares of all classes of stock which the Company is authorized to issue is thirty-eight million (38,000,000) shares of which two million ( 2,000,000 1,000,000 35,000,000 Common Stock On May 8, 2014, the Company issued 869,565 50,000 On October 13, 2014, the Company entered into a private placement offering with an investor to sell 150,000 150,000 150,000 0.20 On April 28, 2015, the Company entered into a private placement offering with an investor to sell 100,000 350,000 100,000 0.40 On July 30, 2015, the Company entered into a private placement offering with an investor to sell 1,000,000 1,000,000 700,000 0.20 300,000 300,000 On August 28, 2015, the Company entered into a private placement offering with an investor to sell 100,000 100,000 70,000 0.20 180,000 180,000 On December 3, 2015, the Company entered into a private placement offering with an investor to sell 500,000 250,000 150,000 0.77 100,000 100,000 As of December 31, 2015 there were 1,850,000 Stock Options 2011 Option Grants On February 23, 2011, the Company entered into an Option Agreement (“Option”) with a company owned 25 In exchange for the rights to the research and development and to further develop the lithium process, the Company granted an option to purchase 1,000,000 0.11 1,000,000 50,000 On February 24, 2011, the Company granted a consultant, which conducted research and development in connection with a proof of lithium process, an option to purchase 100,000 0.11 2013 Option Grants On February 20, 2013, the Company granted its corporate secretary an option to purchase 250,000 0.10 February 20, 2018 vest 25% annually commencing on February 20, 2014 2014 Option Grants On July 28, 2014, the Company granted an advisory board member an option to purchase 250,000 0.20 July 28, 2019 vest 20% annually commencing on July 28, 2015 On September 25, 2014, the Company approved compensatory stock option grants for certain individuals and entities that have provided or have agreed to provide legal, operational and scientific services to the Company. Such grants are accounted for at fair value over the vesting period. On September 25, 2014, the Company granted an employee an option to purchase 100,000 0.20 September 25, 2018 50 150,000 0.20 September 25, 2018 33 420,000 0.20 September 25, 2020 25 1,000,000 0.20 September 25, 2020 20 250,000 0.20 September 25, 2019 25 2015 Option Grants On July 28, 2015, the Company granted an employee an option to purchase 150,000 0.20 July 28, 2020 50 50 On October 13, 2015, the Company granted an employee an option to purchase 300,000 0.36 October 13, 2020 33 On October 20, 2015, Steven M. Fludder was appointed to be the Company’s Chief Executive Officer. Jerome I. Feldman, the Company’s continuing Chairman of the Board, resigned such position in order to bring in Mr. Fludder. Pursuant to a term sheet, the Company granted Mr. Fludder 350,000 650,000 250,000 0.40 100,000 75,000 75,000 On July 28, 2015, the Company granted a consultant an option to purchase 500,000 0.20 July 28, 2019 20 The grant date fair value of stock options granted during the year ended December 31, 2015 and 2014 was approximately $ 135,000 281,000 0 As of December 31, 2015 2014 Exercise price $0.20 - $0.40 $ 0.20 Expected stock price volatility 74.34% - 85.15% 81.62% - 95.10% Risk-free rate of interest 0.69% - 1.78% 1.01% - 1.75% Term (years) 2.0 - 6.5 2.5 - 5.0 A summary of options granted to employees for the year ended December 31, 2015 is presented below: Number of Shares Weighted Average Total Intrinsic Value Weighted Average Outstanding as of January 1, 2015 350,000 $ 0.13 $ 46,000 3.3 Employee options granted 700,000 0.34 455,000 6.5 Outstanding as of December 31, 2015 1,050,000 $ 0.27 $ 756,500 5.1 Options vested and expected to vest 1,050,000 $ 0.27 $ 756,500 5.1 Options vested and exercisable 175,000 $ 0.13 $ 150,750 2.3 A summary of options that the Company granted to non-employees for the year ended December 31, 2015 is presented below: Number of Shares Weighted Average Total Intrinsic Value Weighted Average Outstanding as of January 1, 2015 2,170,000 $ 0.20 $ 289,200 5.1 Non-employee options granted 500,000 0.20 395,000 3.6 Outstanding as of December 31, 2015 2,670,000 $ 0.20 $ 2,118,300 4.0 Options vested and expected to vest 2,670,000 $ 0.20 $ 2,118,300 4.0 Options vested and exercisable 646,500 $ 0.19 $ 519,735 3.5 Estimated future stock-based compensation expense relating to unvested stock options is approximately $ 2.9 A summary of options granted to employees for the year ended December 31, 2014 is presented below: Number of Shares Weighted Average Total Intrinsic Value Weighted Average Outstanding as of January 1, 2014 250,000 $ 0.10 $ 40,000 4.1 Employee options granted 100,000 0.20 6,000 3.7 Outstanding as of December 31, 2014 350,000 $ 0.13 $ 46,000 3.3 Options vested and expected to vest 350,000 $ 0.13 $ 46,000 3.3 Options vested and exercisable 62,500 $ 0.10 $ 10,000 3.1 A summary of options that the Company granted to non-employees for the year ended December 31, 2014 is presented below: Number of Shares Weighted Average Total Intrinsic Value Weighted Average Outstanding as of January 1, 2014 1,100,000 $ 0.11 $ 165,000 2.1 Non-employee options granted 2,070,000 0.20 124,200 5.3 Non-employee options forfeited (1,000,000) 0.11 - - Outstanding as of December 31, 2014 2,170,000 $ 0.20 $ 289,200 5.1 Options vested and expected to vest 2,170,000 $ 0.20 $ 289,200 5.1 Options vested and exercisable 100,000 $ 0.11 $ 15,000 1.1 Restricted Stock On October 20, 2015, Steven M. Fludder was appointed to be the Company’s Chief Executive Officer. Jerome I. Feldman, the Company’s continuing Chairman of the Board, resigned such position in order to bring in Mr. Fludder. Pursuant to a term sheet the Company granted Mr. Fludder 350,000 shares of the Company’s common stock on December 18, 2015 and an additional 650,000 shares of common stock on January 15, 2016. Number of Units Weighted Average Nonvested at January 1, 2015 - $ - Granted 1,000,000 $ 0.40 Vested (350,000) $ 0.40 Nonvested at December 31, 2015 650,000 $ 0.40 Warrants Number of Warrants Weighted Average Total Intrinsic Value Weighted Average Outstanding as of January 1, 2015 500,000 $ 0.34 $ 9,000 4.4 Issued 1,350,000 0.31 924,000 4.6 Outstanding as of December 31, 2015 1,850,000 $ 0.31 $ 1,249,000 4.3 Warrants exercisable 1,850,000 $ 0.31 $ 1,249,000 4.3 A summary of the status of the Company’s outstanding warrants as of December 31, 2014 and changes during the year then ended is presented below: Number of Warrants Weighted Average Total Intrinsic Value Weighted Average Outstanding as of January 1, 2014 - $ - $ - - Issued 500,000 0.34 9,000 4.4 Outstanding as of December 31, 2014 500,000 $ 0.34 $ 9,000 4.4 Warrants exercisable 500,000 $ 0.34 $ 9,000 4.4 Stock-based Compensation Expense For the Years Ended December 31 2015 2014 Employee restricted stock units awards $ 264 $ - Employee stock option awards 30 6 Non-employee option awards 687 44 Total compensation expense $ 981 $ 50

Deferred Tax Assets and Income

Deferred Tax Assets and Income Tax Provision	12 Months Ended
	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	Note 7 – Deferred Tax Assets and Income Tax Provision The Company had no income tax expense due to operating loss incurred for the years ended December 31, 2015 and 2014. As of December 31, 2015 2014 Deferred tax assets: Net-operating loss carryforward $ 342 $ - Stock based compensation 431 20 Total Deferred Tax Assets 773 20 Valuation allowance (773) (20) Net Deferred Tax Asset - - For the year ended 2015 2014 Federal Current $ - $ - Deferred 643 17 State Current - - Deferred 110 3 Change in Valuation Allowance (753) (20) Income Tax Provision (Benefit) - - At December 31, 2015, the Company had net operating loss carry forwards for federal and state tax purposes of approximately $ 900,000 In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and taxing strategies in making this assessment. In case the deferred tax assets will not be realized in future periods, the Company has provided a valuation allowance for the full amount of the deferred tax assets at December 31, 2015. The valuation allowance increased by approximately $ 753,000 20,000 For the years ended December 31, 2015 2014 Statutory Federal Income Tax Rate (34.0) % (34.0) % State Taxes, Net of Federal Tax Benefit (5.8) % (5.8) % Change in Valuation Allowance 39.8 % 39.8 % Income Taxes Provision (Benefit) 0.0 % 0.0 % The Company has not identified any uncertain tax positions requiring a reserve as of December 31, 2015. The Company is in the process of preparing all historical federal and state tax returns. Therefore, the Company’s net operating loss carryovers will not be available to offset future taxable income, if any, until the tax returns are filed.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2015
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 8 – Subsequent Events The Company has evaluated all events that occurred after the balance sheet date through the date when the financial statements were issued to determine if they must be reported. The Company determined that the following reportable subsequent event(s) need to be disclosed: Pursuant to a term sheet relating to Mr. Fludder’s employment offer, the Company issued Mr. Fludder 650,000 On March 22, 2016, the Company entered into a lease (the “Lease”) with Hudson View Building #3, LLC (the “Landlord”), for office and laboratory space located in Yonkers, New York (the “Leased Premise”). The Leased Premise consists of approximately 8,000 87 208,000 1.5 In March and April of 2016, the Company completed private placements with investors issuing 554,689 221,875 355,000 0.97 On June 3, 2016, the Company entered into a private placement offering with an investor to issue 100,000 250,000

Significant and Critical Acco15

Significant and Critical Accounting Policies and Practices (Policies)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation and Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company’s subsidiaries. For consolidated entities where the Company owns less than 100% of the subsidiary, the Company records net income (loss) attributable to non-controlling interests in its consolidated statements of operations equal to the percentage of the economic or ownership interest retained in such entities by the respective non-controlling parties. The Company may consolidate subsidiaries in which it owns less than 50% of the subsidiary but maintains voting control. The Company’s consolidated financial statements include the accounts of the Company and its subsidiaries: Avenue Pictures, Inc., Wombat Productions, Inc. and Clean Lithium Corporation. All intercompany balances and transactions have been eliminated.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The Company’s consolidated financial statements include certain amounts that are based on management’s best estimates and judgments. The Company’s significant estimates include, but are not limited to, useful lives assigned to long-lived assets, fair value measurements, stock-based compensation, accrued expenses, provisions for income taxes and contingencies. Due to the uncertainty inherent in such estimates, actual results may differ from these estimates.
Fair Value Measurement, Policy [Policy Text Block]	Fair Value Measurement The Company follows accounting guidance on fair value measurements for financial assets and liabilities measured at fair value on a recurring basis. Under the accounting guidance, fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. The accounting guidance requires fair value measurements be classified and disclosed in one of the following three categories: Level 1 Level 2: Level 3: The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability. Accounts Payable and Accrued Expenses.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash As of December 31, 2015 and 2014, substantially all of the Company’s cash was held by major financial institutions and the balance at certain times may exceed the maximum amount insured by the Federal Deposits Insurance Corporation (“FDIC”). However, the Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Office equipment is recorded at cost and depreciated using the straight-line method over the estimated useful life of each asset, generally five years.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of Long-Lived Assets The Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value.
Accounting For Warrants [Policy Text Block]	Accounting for Warrants The Company accounts for the issuance of common stock purchase warrants issued in connection with the equity offerings in accordance with the provisions of ASC 815, Derivatives and Hedging (“ASC 815”). The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net-cash settle the contract if an event occurs and if that event is outside the control of the Company) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses the classification of its common stock purchase warrants as of the date of each offering and reassesses such classification at each financial reporting date. The Company determined that such instruments did not meet the criteria for liability classification.
Research and Development Expense, Policy [Policy Text Block]	Research and Development Research and development costs are expensed as incurred. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. Upfront and milestone payments due to third parties that perform research and development services on the Company’s behalf will be expensed as services are rendered or when the milestone is achieved. Research and development costs primarily consist of personnel related expenses, including salaries, benefits, travel, and other related expenses, stock-based compensation, payments made to third parties for license and milestone costs related to in-licensed products and technology, payments made to third party contract research organizations, consultants, the cost of acquiring and manufacturing research trial materials, and costs associated with regulatory filings, laboratory costs and other supplies. In accordance with ASC 730-10-25-1, Research and Development
Commitments and Contingencies, Policy [Policy Text Block]	Contingencies The Company records accruals for contingencies and legal proceedings expected to be incurred in connection with a loss contingency when it is probable that a liability has been incurred and the amount can be reasonably estimated. If a loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation The Company expenses stock-based compensation to employees over the requisite service period based on the estimated grant-date fair value of the awards and forfeiture rates. For stock-based compensation awards to non-employees, the Company remeasures the fair value of the non-employee awards at each reporting period prior to vesting and finally at the vesting date of the award. Changes in the estimated fair value of these non-employee awards are recognized as compensation expense in the period of change. The Company estimates the fair value of stock options grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment.
Income Tax, Policy [Policy Text Block]	Income Taxes The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is greater than 50% likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.
Gain From Extinguishment of Accounts Payable [Policy Text Block]	Gain From Extinguishment of Accounts Payable During the year ended December 31, 2014, the Company settled outstanding debt of $90,000 with its predecessor auditor, Schulman Wolfson & Abruzzo, LLP for $ 10,000 80,000
Earnings Per Share, Policy [Policy Text Block]	Loss Per Share Basic loss per share of common stock is computed by dividing net loss applicable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted loss per share excludes the potential impact of common stock options, unvested shares of restricted stock and outstanding common stock purchase warrants because their effect would be anti-dilutive. As of December 31, 2015 2014 Warrants to purchase common stock 1,850,000 - Options to purchase common stock 3,720,000 2,520,000 Unvested restricted stock 650,000 - Total 6,220,000 2,520,000
Noncontrolling Interest [Policy Text Block]	Non-Controlling Interests Non-controlling interests in consolidated entities represent the component of equity in consolidated entities held by third parties. Any change in ownership of a subsidiary while the controlling financial interest is retained is accounted for as an equity transaction between the controlling and non-controlling interests.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) In March 2016, the FASB issued ASU No. 2016-09, Compensation-Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”)

Organization and Operations (Ta

Organization and Operations (Tables)	12 Months Ended
	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Sale of Subsidiary's Stock And Parent Company's Warrants [Table Text Block]	The sale by the Company of subsidiary stock and alpha-En warrants were as follows: Shares Warrant Value Common Stock Warrants Strike Price Common Stock Warrants Total 2014 October 13, 2014 Clean Lithium Corporation 150,000 - $ 123,000 $ - $ 123,000 alpha-En Corporation - 150,000 $ 0.20 - 27,000 27,000 150,000 150,000 $ 123,000 $ 27,000 $ 150,000 2015 April 28, 2015 Clean Lithium Corporation 100,000 - $ 61,000 $ - $ 61,000 alpha-En Corporation - 350,000 $ 0.40 - 39,000 39,000 July 30, 2015 Clean Lithium Corporation 300,000 - 300,000 - 300,000 alpha-En Corporation - 1,000,000 $ 0.20 - 50,000 50,000 August 28, 2015 Clean Lithium Corporation 180,000 - 180,000 - 180,000 alpha-En Corporation - 100,000 $ 0.20 - 5,000 5,000 December 3, 2015 Clean Lithium Corporation 100,000 - 100,000 - 100,000 alpha-En Corporation - 250,000 $ 0.77 - 30,000 30,000 680,000 1,700,000 $ 641,000 $ 124,000 $ 765,000
Schedule Of Ownership Interest In The Subsidiary Company [Table Text Block]	Following the sale of CLC’s shares, the ownership is as follows: Shareholder Shares Percentage alpha-En Corporation 9,170,000 91.70 % Non-controlling interests 830,000 8.30 % Total: 10,000,000 100.00 %

Significant and Critical Acco17

Significant and Critical Accounting Policies and Practices (Tables)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share at December 31, 2015 and 2014 are as follows: As of December 31, 2015 2014 Warrants to purchase common stock 1,850,000 - Options to purchase common stock 3,720,000 2,520,000 Unvested restricted stock 650,000 - Total 6,220,000 2,520,000

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	The components of property and equipment as of December 31, 2015 and 2014, at cost are (dollars in thousands): As of December 31, ($ in thousands) Useful Life (Years) 2015 2014 Lab equipment 5 $ 2 $ - Total property and equipment 2 - Less: Accumulated depreciation - - Property and equipment, net $ 2 $ -

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Tables)	12 Months Ended
	Dec. 31, 2015
Equity [Abstract]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	The fair value of options granted in 2015 and 2014 was estimated using the following assumptions: As of December 31, 2015 2014 Exercise price $0.20 - $0.40 $ 0.20 Expected stock price volatility 74.34% - 85.15% 81.62% - 95.10% Risk-free rate of interest 0.69% - 1.78% 1.01% - 1.75% Term (years) 2.0 - 6.5 2.5 - 5.0
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	A summary of options granted to employees for the year ended December 31, 2015 is presented below: Number of Shares Weighted Average Total Intrinsic Value Weighted Average Outstanding as of January 1, 2015 350,000 $ 0.13 $ 46,000 3.3 Employee options granted 700,000 0.34 455,000 6.5 Outstanding as of December 31, 2015 1,050,000 $ 0.27 $ 756,500 5.1 Options vested and expected to vest 1,050,000 $ 0.27 $ 756,500 5.1 Options vested and exercisable 175,000 $ 0.13 $ 150,750 2.3 A summary of options that the Company granted to non-employees for the year ended December 31, 2015 is presented below: Number of Shares Weighted Average Total Intrinsic Value Weighted Average Outstanding as of January 1, 2015 2,170,000 $ 0.20 $ 289,200 5.1 Non-employee options granted 500,000 0.20 395,000 3.6 Outstanding as of December 31, 2015 2,670,000 $ 0.20 $ 2,118,300 4.0 Options vested and expected to vest 2,670,000 $ 0.20 $ 2,118,300 4.0 Options vested and exercisable 646,500 $ 0.19 $ 519,735 3.5 Estimated future stock-based compensation expense relating to unvested stock options is approximately $ 2.9 A summary of options granted to employees for the year ended December 31, 2014 is presented below: Number of Shares Weighted Average Total Intrinsic Value Weighted Average Outstanding as of January 1, 2014 250,000 $ 0.10 $ 40,000 4.1 Employee options granted 100,000 0.20 6,000 3.7 Outstanding as of December 31, 2014 350,000 $ 0.13 $ 46,000 3.3 Options vested and expected to vest 350,000 $ 0.13 $ 46,000 3.3 Options vested and exercisable 62,500 $ 0.10 $ 10,000 3.1 A summary of options that the Company granted to non-employees for the year ended December 31, 2014 is presented below: Number of Shares Weighted Average Total Intrinsic Value Weighted Average Outstanding as of January 1, 2014 1,100,000 $ 0.11 $ 165,000 2.1 Non-employee options granted 2,070,000 0.20 124,200 5.3 Non-employee options forfeited (1,000,000) 0.11 - - Outstanding as of December 31, 2014 2,170,000 $ 0.20 $ 289,200 5.1 Options vested and expected to vest 2,170,000 $ 0.20 $ 289,200 5.1 Options vested and exercisable 100,000 $ 0.11 $ 15,000 1.1
Nonvested Restricted Stock Shares Activity [Table Text Block]	A summary of the restricted stock award activity for the year ended December 31, 2015 is as follows: Number of Units Weighted Average Nonvested at January 1, 2015 - $ - Granted 1,000,000 $ 0.40 Vested (350,000) $ 0.40 Nonvested at December 31, 2015 650,000 $ 0.40
Schedule of Warrants Activity [Table Text Block]	A summary of the status of the Company’s outstanding warrants as of December 31, 2015 and changes during the year then ended is presented below: Number of Warrants Weighted Average Total Intrinsic Value Weighted Average Outstanding as of January 1, 2015 500,000 $ 0.34 $ 9,000 4.4 Issued 1,350,000 0.31 924,000 4.6 Outstanding as of December 31, 2015 1,850,000 $ 0.31 $ 1,249,000 4.3 Warrants exercisable 1,850,000 $ 0.31 $ 1,249,000 4.3 A summary of the status of the Company’s outstanding warrants as of December 31, 2014 and changes during the year then ended is presented below: Number of Warrants Weighted Average Total Intrinsic Value Weighted Average Outstanding as of January 1, 2014 - $ - $ - - Issued 500,000 0.34 9,000 4.4 Outstanding as of December 31, 2014 500,000 $ 0.34 $ 9,000 4.4 Warrants exercisable 500,000 $ 0.34 $ 9,000 4.4
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]	Stock-based compensation expense for the year ended December 31, 2015 and 2014 was comprised of the following (in thousands): For the Years Ended December 31 2015 2014 Employee restricted stock units awards $ 264 $ - Employee stock option awards 30 6 Non-employee option awards 687 44 Total compensation expense $ 981 $ 50

Deferred Tax Assets and Incom20

Deferred Tax Assets and Income Tax Provision (Tables)	12 Months Ended
	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	The tax effects of temporary differences and tax loss and credit carry forwards that give rise to significant portions of deferred tax assets and liabilities at December 31, 2015 and 2014 are comprised of the following (dollars in thousands): As of December 31, 2015 2014 Deferred tax assets: Net-operating loss carryforward $ 342 $ - Stock based compensation 431 20 Total Deferred Tax Assets 773 20 Valuation allowance (773) (20) Net Deferred Tax Asset - -
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	For the year ended 2015 2014 Federal Current $ - $ - Deferred 643 17 State Current - - Deferred 110 3 Change in Valuation Allowance (753) (20) Income Tax Provision (Benefit) - -
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	For the years ended December 31, 2015 2014 Statutory Federal Income Tax Rate (34.0) % (34.0) % State Taxes, Net of Federal Tax Benefit (5.8) % (5.8) % Change in Valuation Allowance 39.8 % 39.8 % Income Taxes Provision (Benefit) 0.0 % 0.0 %

Organization and Operations (De

Organization and Operations (Details) - USD ($)	1 Months Ended		12 Months Ended
	Aug. 28, 2015	Jul. 30, 2015	Dec. 31, 2015	Dec. 31, 2014	Apr. 28, 2015	Oct. 13, 2014
Sale of Stock, Consideration Received on Transaction			$ 765,000	$ 150,000
Warrant [Member]
Sale of Stock, Number of Shares Issued in Transaction			1,700,000	150,000
Sale of Stock, Consideration Received on Transaction			$ 124,000	$ 27,000
Common Stock [Member]
Sale of Stock, Number of Shares Issued in Transaction			680,000	150,000
Sale of Stock, Consideration Received on Transaction			$ 641,000	$ 123,000
Sale Of Stock On Thirteenth October Two Thousand Fourteen [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 0.20
Sale Of Stock On Twenty Eight April Two Thousand Fifteen [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 0.40
Sale Of Stock On Twenty Eight April Two Thousand Fifteen [Member] | Warrant [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 0.40
Sale Of Stock On Thrity July Two Thousand Fifteen [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.20
Sale Of Stock On Thrity July Two Thousand Fifteen [Member] | Warrant [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights			0.20
Sale Of Stock On Twenty Eight August Two Thousand Fifteen [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.20
Sale Of Stock On Twenty Eight August Two Thousand Fifteen [Member] | Warrant [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights			0.20
Sale Of Stock On Third December Two Thousand Fifteen [Member] | Warrant [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 0.77
Clean Lithium Corporation [Member] | Sale Of Stock On Thirteenth October Two Thousand Fourteen [Member]
Sale of Stock, Consideration Received on Transaction				$ 123,000
Clean Lithium Corporation [Member] | Sale Of Stock On Thirteenth October Two Thousand Fourteen [Member] | Warrant [Member]
Sale of Stock, Number of Shares Issued in Transaction				0
Sale of Stock, Consideration Received on Transaction				$ 0
Clean Lithium Corporation [Member] | Sale Of Stock On Thirteenth October Two Thousand Fourteen [Member] | Common Stock [Member]
Sale of Stock, Number of Shares Issued in Transaction				150,000
Sale of Stock, Consideration Received on Transaction				$ 123,000
Clean Lithium Corporation [Member] | Sale Of Stock On Twenty Eight April Two Thousand Fifteen [Member]
Sale of Stock, Consideration Received on Transaction			$ 61,000
Clean Lithium Corporation [Member] | Sale Of Stock On Twenty Eight April Two Thousand Fifteen [Member] | Warrant [Member]
Sale of Stock, Number of Shares Issued in Transaction			0
Sale of Stock, Consideration Received on Transaction			$ 0
Clean Lithium Corporation [Member] | Sale Of Stock On Twenty Eight April Two Thousand Fifteen [Member] | Common Stock [Member]
Sale of Stock, Number of Shares Issued in Transaction			100,000
Sale of Stock, Consideration Received on Transaction			$ 61,000
Clean Lithium Corporation [Member] | Sale Of Stock On Thrity July Two Thousand Fifteen [Member]
Sale of Stock, Number of Shares Issued in Transaction		300,000
Sale of Stock, Consideration Received on Transaction			$ 300,000
Clean Lithium Corporation [Member] | Sale Of Stock On Thrity July Two Thousand Fifteen [Member] | Warrant [Member]
Sale of Stock, Number of Shares Issued in Transaction			0
Sale of Stock, Consideration Received on Transaction			$ 0
Clean Lithium Corporation [Member] | Sale Of Stock On Thrity July Two Thousand Fifteen [Member] | Common Stock [Member]
Sale of Stock, Number of Shares Issued in Transaction			300,000
Sale of Stock, Consideration Received on Transaction			$ 300,000
Clean Lithium Corporation [Member] | Sale Of Stock On Twenty Eight August Two Thousand Fifteen [Member]
Sale of Stock, Number of Shares Issued in Transaction	180,000
Sale of Stock, Consideration Received on Transaction			$ 180,000
Clean Lithium Corporation [Member] | Sale Of Stock On Twenty Eight August Two Thousand Fifteen [Member] | Warrant [Member]
Sale of Stock, Number of Shares Issued in Transaction			0
Sale of Stock, Consideration Received on Transaction			$ 0
Clean Lithium Corporation [Member] | Sale Of Stock On Twenty Eight August Two Thousand Fifteen [Member] | Common Stock [Member]
Sale of Stock, Number of Shares Issued in Transaction			180,000
Sale of Stock, Consideration Received on Transaction			$ 180,000
Clean Lithium Corporation [Member] | Sale Of Stock On Third December Two Thousand Fifteen [Member]
Sale of Stock, Consideration Received on Transaction			$ 100,000
Clean Lithium Corporation [Member] | Sale Of Stock On Third December Two Thousand Fifteen [Member] | Warrant [Member]
Sale of Stock, Number of Shares Issued in Transaction			0
Sale of Stock, Consideration Received on Transaction			$ 0
Clean Lithium Corporation [Member] | Sale Of Stock On Third December Two Thousand Fifteen [Member] | Common Stock [Member]
Sale of Stock, Number of Shares Issued in Transaction			100,000
Sale of Stock, Consideration Received on Transaction			$ 100,000
Alpha-En Corporation [Member] | Sale Of Stock On Thirteenth October Two Thousand Fourteen [Member]
Sale of Stock, Consideration Received on Transaction				$ 27,000
Alpha-En Corporation [Member] | Sale Of Stock On Thirteenth October Two Thousand Fourteen [Member] | Warrant [Member]
Sale of Stock, Number of Shares Issued in Transaction				150,000
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.20
Sale of Stock, Consideration Received on Transaction				$ 27,000
Alpha-En Corporation [Member] | Sale Of Stock On Thirteenth October Two Thousand Fourteen [Member] | Common Stock [Member]
Sale of Stock, Number of Shares Issued in Transaction				0
Sale of Stock, Consideration Received on Transaction				$ 0
Alpha-En Corporation [Member] | Sale Of Stock On Twenty Eight April Two Thousand Fifteen [Member]
Sale of Stock, Consideration Received on Transaction			$ 39,000
Alpha-En Corporation [Member] | Sale Of Stock On Twenty Eight April Two Thousand Fifteen [Member] | Warrant [Member]
Sale of Stock, Number of Shares Issued in Transaction			350,000
Sale of Stock, Consideration Received on Transaction			$ 39,000
Alpha-En Corporation [Member] | Sale Of Stock On Twenty Eight April Two Thousand Fifteen [Member] | Common Stock [Member]
Sale of Stock, Number of Shares Issued in Transaction			0
Sale of Stock, Consideration Received on Transaction			$ 0
Alpha-En Corporation [Member] | Sale Of Stock On Thrity July Two Thousand Fifteen [Member]
Sale of Stock, Consideration Received on Transaction			$ 50,000
Alpha-En Corporation [Member] | Sale Of Stock On Thrity July Two Thousand Fifteen [Member] | Warrant [Member]
Sale of Stock, Number of Shares Issued in Transaction			1,000,000
Sale of Stock, Consideration Received on Transaction			$ 50,000
Alpha-En Corporation [Member] | Sale Of Stock On Thrity July Two Thousand Fifteen [Member] | Common Stock [Member]
Sale of Stock, Number of Shares Issued in Transaction			0
Sale of Stock, Consideration Received on Transaction			$ 0
Alpha-En Corporation [Member] | Sale Of Stock On Twenty Eight August Two Thousand Fifteen [Member]
Sale of Stock, Consideration Received on Transaction			$ 5,000
Alpha-En Corporation [Member] | Sale Of Stock On Twenty Eight August Two Thousand Fifteen [Member] | Warrant [Member]
Sale of Stock, Number of Shares Issued in Transaction			100,000
Sale of Stock, Consideration Received on Transaction			$ 5,000
Alpha-En Corporation [Member] | Sale Of Stock On Twenty Eight August Two Thousand Fifteen [Member] | Common Stock [Member]
Sale of Stock, Number of Shares Issued in Transaction			0
Sale of Stock, Consideration Received on Transaction			$ 0
Alpha-En Corporation [Member] | Sale Of Stock On Third December Two Thousand Fifteen [Member]
Sale of Stock, Consideration Received on Transaction			$ 30,000
Alpha-En Corporation [Member] | Sale Of Stock On Third December Two Thousand Fifteen [Member] | Warrant [Member]
Sale of Stock, Number of Shares Issued in Transaction			250,000
Sale of Stock, Consideration Received on Transaction			$ 30,000
Alpha-En Corporation [Member] | Sale Of Stock On Third December Two Thousand Fifteen [Member] | Common Stock [Member]
Sale of Stock, Number of Shares Issued in Transaction			0
Sale of Stock, Consideration Received on Transaction			$ 0

Organization and Operations (22

Organization and Operations (Details 1) - Clean Lithium Corporation [Member]	Dec. 03, 2015shares
Shares, Outstanding	10,000,000
Equity Method Investment, Ownership Percentage	100.00%
Parent [Member]
Shares, Outstanding	9,170,000
Equity Method Investment, Ownership Percentage	91.70%
Noncontrolling Interest [Member]
Shares, Outstanding	830,000
Equity Method Investment, Ownership Percentage	8.30%

Organization and Operations (23

Organization and Operations (Details Textual)	Sep. 30, 2014USD ($)
Clean Lithium Corporation [Member]
Franchisor Disclosure [Line Items]
Capital	$ 100,000

Significant and Critical Acco24

Significant and Critical Accounting Policies and Practices (Details) - shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Franchisor Disclosure [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	6,220,000	2,520,000
Warrant [Member]
Franchisor Disclosure [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,850,000	0
Restricted Stock [Member]
Franchisor Disclosure [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	650,000	0
Employee Stock Option [Member]
Franchisor Disclosure [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,720,000	2,520,000

Significant and Critical Acco25

Significant and Critical Accounting Policies and Practices (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Due to Related Parties, Current	$ 62,000	$ 138,000
Repayments of Related Party Debt	87,000	13,000
Gain (Loss) on Extinguishment of Debt	$ 0	80,000
Office Equipment [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Schulman Wolfson Abruzzo, LLP [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Due to Related Parties, Current		90,000
Repayments of Related Party Debt		$ 10,000

Going Concern and Liquidity (De

Going Concern and Liquidity (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Retained Earnings (Accumulated Deficit)	$ (10,169)	$ (8,377)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	(1,841)	(47)
Net Cash Provided by (Used in) Operating Activities, Continuing Operations	$ (895)	$ (95)

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 2	$ 0
Less: Accumulated depreciation	0	0
Property and equipment, net	$ 2	0
Lab equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Total property and equipment	$ 2	$ 0

Property and Equipment (Detai28

Property and Equipment (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 0	$ 0

Related Party Transactions (Det

Related Party Transactions (Details Textual) - USD ($)	Oct. 13, 2015	Jul. 28, 2015	Jul. 28, 2014	Feb. 20, 2013	Feb. 24, 2011	Dec. 31, 2015	Dec. 31, 2014
Related Party Transaction [Line Items]
Proceeds from Related Party Debt						$ 11,000	$ 60,000
Repayments of Related Party Debt						87,000	$ 13,000
Debt Conversion, Converted Instrument, Shares Issued							869,565
Debt Conversion, Original Debt, Amount							$ 50,000
Due to Related Parties, Current						62,000	138,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	300,000	150,000	250,000	250,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 0.36	$ 0.20	$ 0.20	$ 0.10	$ 0.11
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Fair Value						135,000	$ 281,000
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Accrued Payroll Taxes, Current						60,826
Payments Related to Tax Withholding for Share-based Compensation						$ 60,826
Son of of Board of Directors [Member]
Related Party Transaction [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross							420,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price							$ 0.20
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period							6 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Fair Value							$ 55,000

Stockholders' Equity (Deficit30

Stockholders' Equity (Deficit) (Details) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Exercise price		$ 0.20
Maximum [Member]
Exercise price	$ 0.40
Expected stock price volatility	85.15%	95.10%
Risk-free rate of interest	1.78%	1.75%
Term (years)	6 years 6 months	5 years
Minimum [Member]
Exercise price	$ 0.20
Expected stock price volatility	74.34%	81.62%
Risk-free rate of interest	0.69%	1.01%
Term (years)	2 years	2 years 6 months

Stockholders' Equity (Deficit31

Stockholders' Equity (Deficit) (Details 1) - USD ($)	Oct. 13, 2015	Jul. 28, 2015	Jul. 28, 2014	Feb. 20, 2013	Feb. 24, 2011	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted, Shares	300,000	150,000	250,000	250,000
Outstanding, Weighted Average Exercise Price						$ 0.20
Options granted, Weighted Average Exercise Price	$ 0.36	$ 0.20	$ 0.20	$ 0.10	$ 0.11
Outstanding, Weighted Average Exercise Price							$ 0.20
Outstanding, Intrinsic Value					$ 100,000
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding, Shares						350,000	250,000
Options granted, Shares						700,000	100,000
Outstanding, Shares						1,050,000	350,000	250,000
Options vested and expected to vest, Shares						1,050,000	350,000
Options vested and exercisable, Shares						175,000	62,500
Outstanding, Weighted Average Exercise Price						$ 0.13	$ 0.10
Options granted, Weighted Average Exercise Price						0.34	0.20
Outstanding, Weighted Average Exercise Price						0.27	0.13	$ 0.10
Options vested and expected to vest, Weighted Average Exercise Price						0.27	0.13
Options vested and exercisable, Weighted Average Exercise Price						$ 0.13	$ 0.10
Outstanding, Intrinsic Value						$ 46,000	$ 40,000
Options granted, Intrinsic Value						455,000	6,000
Outstanding, Intrinsic Value						756,500	46,000	$ 40,000
Options vested and expected to vest, Intrinsic Value						756,500	46,000
Options vested and exercisable, Intrinsic Value						$ 150,750	$ 10,000
Outstanding, Contractual Life						5 years 1 month 6 days	3 years 3 months 18 days	4 years 1 month 6 days
Options granted, Contractual Life						6 years 6 months	3 years 8 months 12 days
Options vested and expected to vest, Contractual Life						5 years 1 month 6 days	3 years 3 months 18 days
Options vested and exercisable, Contractual Life						2 years 3 months 18 days	3 years 1 month 6 days
Non Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding, Shares						2,170,000	1,100,000
Options granted, Shares						500,000	2,070,000
Options forfeited, Shares							(1,000,000)
Outstanding, Shares						2,670,000	2,170,000	1,100,000
Options vested and expected to vest, Shares						2,670,000	2,170,000
Options vested and exercisable, Shares						646,500	100,000
Outstanding, Weighted Average Exercise Price						$ 0.20	$ 0.11
Options granted, Weighted Average Exercise Price						0.20	0.20
Options forfeited, Weighted Average Exercise Price							0.11
Outstanding, Weighted Average Exercise Price						0.20	0.20	$ 0.11
Options vested and expected to vest, Weighted Average Exercise Price						0.20	0.20
Options vested and exercisable, Weighted Average Exercise Price						$ 0.19	$ 0.11
Outstanding, Intrinsic Value						$ 289,200	$ 165,000
Options granted, Intrinsic Value						395,000	124,200
Outstanding, Intrinsic Value						2,118,300	289,200	$ 165,000
Options vested and expected to vest, Intrinsic Value						2,118,300	289,200
Options vested and exercisable, Intrinsic Value						$ 519,735	$ 15,000
Outstanding, Contractual Life						4 years	5 years 1 month 6 days	2 years 1 month 6 days
Options granted, Contractual Life						3 years 7 months 6 days	5 years 3 months 18 days
Options vested and expected to vest, Contractual Life						4 years	5 years 1 month 6 days
Options vested and exercisable, Contractual Life						3 years 6 months	1 year 1 month 6 days

Stockholders' Equity (Deficit32

Stockholders' Equity (Deficit) (Details 2) - Restricted Stock [Member]	12 Months Ended
	Dec. 31, 2015$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Nonvested,Number of Units at January 1, 2015 | shares	0
Granted,Number of Units | shares	1,000,000
Vested, Number of Units | shares	(350,000)
Nonvested, Number of Units at December 31, 2015 | shares	650,000
Nonvested, Weighted Average at January 1, 2015 | $ / shares	$ 0
Granted,Weighted Average | $ / shares	0.40
Vested, Weighted Average | $ / shares	0.40
Nonvested at December 31, 2015 | $ / shares	$ 0.40

Stockholders' Equity (Deficit33

Stockholders' Equity (Deficit) (Details 3) - Warrant [Member] - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Nonvested,Number of Units at January 1, 2015	500,000	0
Issued, Number of Warrant	1,350,000	500,000
Nonvested, Number of Units at December 31, 2015	1,850,000	500,000	0
Warrants exercisable, Number of Warrants	1,850,000	500,000
Outstanding, Weighted Average Exercise Price at January 1, 2015	$ 0.34	$ 0
Issued, Weighted Average Exercise Price	0.31	0.34
Outstanding, Weighted Average Exercise Price at December 31, 2015	0.31	0.34	$ 0
Warrants exercisable, Weighted Average Exercise Price	$ 0.31	$ 0.34
Outstanding, Intrinsic Value as of January 1, 2015	$ 9,000	$ 0
Issued, Intrinsic Value	924,000	9,000
Outstanding, Intrinsic Value as of December 31, 2015	1,249,000	9,000	$ 0
Warrants exercisable, Intrinsic Value	$ 1,249,000	$ 9,000
Outstanding, Contractual Life	4 years 3 months 18 days	4 years 4 months 24 days	0 years
Issued, Contractual Life	4 years 7 months 6 days	4 years 4 months 24 days
Warrants exercisable, Contractual Life	4 years 3 months 18 days	4 years 4 months 24 days

Stockholders' Equity (Deficit34

Stockholders' Equity (Deficit) (Details 4) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee restricted stock units awards	$ 264	$ 0
Share-based Compensation	981	50
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock or Unit Option Plan Expense	30	6
Non Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock or Unit Option Plan Expense	$ 687	$ 44

Stockholders' Equity (Deficit35

Stockholders' Equity (Deficit) (Details Textual) - USD ($)

Jan. 15, 2016

Dec. 03, 2015

Oct. 13, 2015

Oct. 13, 2014

May 09, 2014

May 08, 2014

Dec. 18, 2015

Oct. 20, 2015

Aug. 28, 2015

Jul. 30, 2015

Jul. 28, 2015

Apr. 28, 2015

Sep. 25, 2014

Jul. 28, 2014

Feb. 20, 2013

Feb. 24, 2011

Feb. 23, 2011

Dec. 31, 2015

Dec. 31, 2014

Class of Stock [Line Items]

Total Shares Authorized

38,000,000

Common Stock, Shares Authorized

35,000,000

35,000,000

Common Stock, Par or Stated Value Per Share

$ 0.01

$ 0.01

Preferred Stock, Shares Authorized

2,000,000

2,000,000

Preferred Stock, Par or Stated Value Per Share

$ 0.01

$ 0.01

Share-based Compensation Arrangement by Share-based Payment Award, Options, Value Forfeitures in Period

$ 50,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

300,000

150,000

250,000

250,000

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$ 0.36

$ 0.20

$ 0.20

$ 0.10

$ 0.11

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value

$ 100,000

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date

Oct. 13, 2020

Jul. 28, 2020

Jul. 28, 2019

Feb. 20, 2018

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

vest 20% annually commencing on July 28, 2015

vest 25% annually commencing on February 20, 2014

Stock Issued During Period, Shares, Conversion of Convertible Securities

869,565

Stock Issued During Period, Value, Conversion of Convertible Securities

$ 50,000

Class of Warrant or Right, Outstanding

1,850,000

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options

$ 2,900,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Fair Value

$ 135,000

$ 281,000

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

0.00%

Deferred Compensation Arrangement with Individual, Exercise Price

$ 0.40

Employee Stock Option [Member]

Class of Stock [Line Items]

Deferred Compensation Arrangement with Individual, Shares Issued

250,000

Share-based Compensation Award, Tranche One [Member]

Class of Stock [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

50.00%

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares

100,000

Share-based Compensation Award, Tranche Two [Member]

Class of Stock [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

50.00%

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares

75,000

Share-based Compensation Award, Tranche Three [Member]

Class of Stock [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares

75,000

Option Grants [Member]

Class of Stock [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

33.00%

Investor [Member] | Option Grants [Member]

Class of Stock [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

150,000

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$ 0.20

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date

Sep. 25, 2018

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

33.00%

Number of Employees, Total [Member]

Class of Stock [Line Items]

Class of Warrant or Right, Issued

1,850,000

Sale Of Stock On Thirteenth October Two Thousand Fourteen [Member]

Class of Stock [Line Items]

Stock Issued During Period, Value, New Issues

$ 150,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.20

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

5 years

Sale Of Stock On Twenty Eight April Two Thousand Fifteen [Member]

Class of Stock [Line Items]

Stock Issued During Period, Value, New Issues

$ 100,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.40

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

4 years

Sale Of Stock On Thrity July Two Thousand Fifteen [Member]

Class of Stock [Line Items]

Stock Issued During Period, Value, New Issues

$ 700,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.20

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

5 years

Sale Of Stock On Thrity July Two Thousand Fifteen [Member] | Clean Lithium Corporation [Member]

Class of Stock [Line Items]

Stock Issued During Period, Value, New Issues

$ 300,000

Sale of Stock, Number of Shares Issued in Transaction

300,000

Sale Of Stock On Twenty Eight August Two Thousand Fifteen [Member]

Class of Stock [Line Items]

Stock Issued During Period, Value, New Issues

$ 70,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.20

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

5 years

Sale Of Stock On Twenty Eight August Two Thousand Fifteen [Member] | Clean Lithium Corporation [Member]

Class of Stock [Line Items]

Stock Issued During Period, Value, New Issues

$ 180,000

Sale of Stock, Number of Shares Issued in Transaction

180,000

Sale Of Stock On Third December Three Thousand Fifteen [Member]

Class of Stock [Line Items]

Stock Issued During Period, Value, New Issues

$ 150,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.77

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

5 years

Sale Of Stock On Third December Three Thousand Fifteen [Member] | Clean Lithium Corporation [Member]

Class of Stock [Line Items]

Stock Issued During Period, Value, New Issues

$ 100,000

Sale of Stock, Number of Shares Issued in Transaction

100,000

Employee [Member] | Option Grants [Member]

Class of Stock [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

100,000

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$ 0.20

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date

Sep. 25, 2018

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

50.00%

Consultant [Member] | Option Grants [Member]

Class of Stock [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

500,000

420,000

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$ 0.20

$ 0.20

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date

Jul. 28, 2019

Sep. 25, 2020

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

20.00%

25.00%

Consultant One [Member] | Option Grants [Member]

Class of Stock [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

1,000,000

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$ 0.20

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date

Sep. 25, 2020

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

20.00%

Advisory Board [Member] | Option Grants [Member]

Class of Stock [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

250,000

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$ 0.20

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date

Sep. 25, 2019

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

25.00%

Option Agreement [Member]

Class of Stock [Line Items]

Percentage of Shareholders In Option Agreement

25.00%

Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award

1,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number

0.11

Option Agreement [Member] | May 08, 2014 [Member]

Class of Stock [Line Items]

Share Based Compensation Arrangement By Share Based Payment Award Option Value

$ 1,000,000

Common Stock [Member]

Class of Stock [Line Items]

Deferred Compensation Arrangement with Individual, Fair Value of Shares Issued

$ 350,000

Common Stock [Member] | Sale Of Stock On Thirteenth October Two Thousand Fourteen [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

150,000

Common Stock [Member] | Sale Of Stock On Twenty Eight April Two Thousand Fifteen [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

100,000

Common Stock [Member] | Sale Of Stock On Thrity July Two Thousand Fifteen [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

1,000,000

Common Stock [Member] | Sale Of Stock On Twenty Eight August Two Thousand Fifteen [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

100,000

Common Stock [Member] | Sale Of Stock On Third December Three Thousand Fifteen [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

500,000

Common Stock [Member] | Subsequent Event [Member]

Class of Stock [Line Items]

Deferred Compensation Arrangement with Individual, Fair Value of Shares Issued

$ 650,000

Warrant [Member]

Class of Stock [Line Items]

Sale of Stock, Number of Shares Issued in Transaction

1,700,000

150,000

Warrant [Member] | Sale Of Stock On Thirteenth October Two Thousand Fourteen [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

150,000

Warrant [Member] | Sale Of Stock On Thirteenth October Two Thousand Fourteen [Member] | Clean Lithium Corporation [Member]

Class of Stock [Line Items]

Sale of Stock, Number of Shares Issued in Transaction

0

Warrant [Member] | Sale Of Stock On Twenty Eight April Two Thousand Fifteen [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

350,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.40

Warrant [Member] | Sale Of Stock On Twenty Eight April Two Thousand Fifteen [Member] | Clean Lithium Corporation [Member]

Class of Stock [Line Items]

Sale of Stock, Number of Shares Issued in Transaction

0

Warrant [Member] | Sale Of Stock On Thrity July Two Thousand Fifteen [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

1,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.20

Warrant [Member] | Sale Of Stock On Thrity July Two Thousand Fifteen [Member] | Clean Lithium Corporation [Member]

Class of Stock [Line Items]

Sale of Stock, Number of Shares Issued in Transaction

0

Warrant [Member] | Sale Of Stock On Twenty Eight August Two Thousand Fifteen [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

100,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.20

Warrant [Member] | Sale Of Stock On Twenty Eight August Two Thousand Fifteen [Member] | Clean Lithium Corporation [Member]

Class of Stock [Line Items]

Sale of Stock, Number of Shares Issued in Transaction

0

Warrant [Member] | Sale Of Stock On Third December Three Thousand Fifteen [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

250,000

Common Class B [Member]

Class of Stock [Line Items]

Common Stock, Shares Authorized

1,000,000

1,000,000

Deferred Tax Assets and Incom36

Deferred Tax Assets and Income Tax Provision (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Deferred tax assets:
Net-operating loss carryforward	$ 342	$ 0
Stock based compensation	431	20
Total Deferred Tax Assets	773	20
Valuation allowance	(773)	(20)
Net Deferred Tax Asset	$ 0	$ 0

Deferred Tax Assets and Incom37

Deferred Tax Assets and Income Tax Provision (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Federal
Current	$ 0	$ 0
Deferred	643	17
State
Current	0	0
Deferred	110	3
Change in Valuation Allowance	(753)	(20)
Income Tax Provision (Benefit)	$ 0	$ 0

Deferred Tax Assets and Incom38

Deferred Tax Assets and Income Tax Provision (Details 2)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Statutory Federal Income Tax Rate	(34.00%)	(34.00%)
State Taxes, Net of Federal Tax Benefit	(5.80%)	(5.80%)
Change in Valuation Allowance	39.80%	39.80%
Income Taxes Provision (Benefit)	0.00%	0.00%

Deferred Tax Assets and Incom39

Deferred Tax Assets and Income Tax Provision (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Operating Loss Carryforwards	$ 900,000
Operating Loss Carryforwards, Expiration Date	Dec. 31, 2035
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 753,000	$ 20,000

Subsequent Events (Details Text

Subsequent Events (Details Textual)	Jun. 03, 2016USD ($)shares	Sep. 30, 2016USD ($)$ / sharesshares	Aug. 31, 2016$ / sharesshares	Mar. 22, 2016USD ($)ft²	Jan. 30, 2016shares	Apr. 30, 2016USD ($)$ / sharesshares
Scenario, Forecast [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues	100,000
Proceeds from Issuance of Private Placement | $	$ 250,000	$ 100,000				$ 355,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares						$ 0.97
Scenario, Forecast [Member] | Warrant [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues		100,000	221,875			221,875
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 2.94	$ 2.70
Warrant Expiration Term			5 years
Common Stock [Member] | Scenario, Forecast [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues		40,000				554,689
Subsequent Event [Member]
Subsequent Event [Line Items]
Area of Land | ft²				8,000
Lessee Leasing Arrangements, Operating Leases, Term of Contract				87 months
Operating Leases, Rent Expense | $				$ 208,000
Operating Leases of Lessee, Contingent Rentals, Basis Spread on Variable Rate				1.50%
Subsequent Event [Member] | Chief Executive Officer [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues					650,000